Assetmark, Inc Spdr Ser Tr Spdr S&P Biotech E Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Assetmark, Inc holds 589,299 shares of XBI stock, worth $55.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

589,299

Previous 810 72652.96%

Holding current value

$55.7 Million

Previous $75,000 77529.33%

% of portfolio

0.17%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$90.87 - $102.43 $53.5 Million - $60.3 Million	588,489 Added 72652.96%	589,299 $58.2 Million
Q2 2024 Aug 13, 2024	BUY	$82.22 - $94.12 $59,609 - $68,237	725 Added 852.94%	810 $75,000
Q1 2024 May 06, 2024	SELL	$87.05 - $102.89 $5,397 - $6,379	-62 Reduced 42.18%	85 $8,000
Q4 2023 Feb 09, 2024	SELL	$64.12 - $90.86 $512 - $726	-8 Reduced 5.16%	147 $13,000
Q3 2023 Oct 27, 2023	SELL	$71.88 - $85.76 $359 - $428	-5 Reduced 3.13%	155 $11,000
Q2 2023 Aug 11, 2023	SELL	$75.38 - $90.23 $150 - $180	-2 Reduced 1.23%	160 $13,000
Q1 2023 May 05, 2023	BUY	$73.13 - $91.97 $146 - $183	2 Added 1.25%	162 $12,000
Q4 2022 Feb 10, 2023	SELL	$76.72 - $85.66 $9,896 - $11,050	-129 Reduced 44.64%	160 $13,000
Q3 2022 Nov 01, 2022	BUY	$75.06 - $94.9 $5,404 - $6,832	72 Added 33.18%	289 $23,000
Q2 2022 Aug 03, 2022	SELL	$62.81 - $96.09 $62.5 Million - $95.6 Million	-994,557 Reduced 99.98%	217 $16,000
Q1 2022 May 13, 2022	BUY	$81.07 - $115.44 $80.6 Million - $115 Million	994,761 Added 7652007.5%	994,774 $89.4 Million
Q4 2021 Feb 14, 2022	SELL	$108.77 - $134.15 $2,719 - $3,353	-25 Reduced 65.79%	13 $1,000
Q3 2021 Nov 12, 2021	BUY	$118.69 - $138.49 $949 - $1,107	8 Added 26.67%	38 $5,000
Q2 2021 Aug 16, 2021	SELL	$122.48 - $139.69 $734 - $838	-6 Reduced 16.67%	30 $4,000
Q1 2021 May 14, 2021	BUY	$129.36 - $173.99 $129 - $173	1 Added 2.86%	36 $5,000
Q4 2020 Feb 10, 2021	BUY	$110.36 - $151.14 $551 - $755	5 Added 16.67%	35 $5,000
Q4 2019 Feb 11, 2020	SELL	$74.65 - $98.46 $1,716 - $2,264	-23 Reduced 43.4%	30 $3,000
Q3 2019 Nov 13, 2019	SELL	$76.25 - $83.86 $2,516 - $2,767	-33 Reduced 38.37%	53 $4,000
Q2 2019 Aug 14, 2019	SELL	N/A	-113 Reduced 56.78%	86 $8,000
Q4 2018 Feb 13, 2019	SELL	N/A	-830,528 Reduced 99.98%	199 $14,000
Q3 2018 Nov 13, 2018	SELL	N/A	-433,286 Reduced 34.28%	830,727 $79.6 Million
Q2 2018 Aug 01, 2018	BUY	N/A	1,263,547 Added 271147.41%	1,264,013 $120 Million
Q1 2018 May 16, 2018	SELL	N/A	-798,812 Reduced 99.94%	466 $41,000
Q4 2017 Feb 13, 2018	SELL	N/A	-439,773 Reduced 35.49%	799,278 $67.8 Million
Q3 2017 Nov 08, 2017	BUY	N/A	464,246 Added 59.92%	1,239,051 $107 Million
Q2 2017 Aug 15, 2017	SELL	N/A	-601,050 Reduced 43.69%	774,805 $59.8 Million
Q1 2017 Sep 15, 2017	BUY	N/A	1,375,855	1,375,855 $95.4 Million

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account